Nature neuroscience

TDP-43-related misprocessing of a potassium channel gene causes nerve cell overactivity in ALS and FTD

Updated

Abstract

TAR DNA-binding protein 43 () dysfunction is associated with mis-splicing of the gene, which regulates neuronal excitability.

  • Nuclear depletion and cytoplasmic aggregation of TDP-43 are common in amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD).
  • Mis-splicing of KCNQ2 leads to a nonfunctional voltage-gated potassium channel that severely reduces ion conductance.
  • This mis-spliced mRNA avoids degradation and results in protein aggregation in the endoplasmic reticulum.
  • Intrinsic hyperexcitability in ALS neuronal models is linked to the dysfunction of KCNQ2 caused by TDP-43 mis-splicing.
  • Higher phosphorylated TDP-43 levels and earlier disease onset in patients correlate with the observed splicing changes.
  • Splice-modulating antisense oligonucleotides can rescue hyperexcitability in neurons affected by TDP-43 depletion.

Simplified

Key numbers

60-fold
Increase in mis-spliced transcripts
Measured in -depleted neurons treated with siRNA.
0.0053
Association with earlier disease onset
P-value for the correlation between levels and age of onset.
< 0.0001
Higher phosphorylated levels
P-value indicating the relationship between mis-spliced and phosphorylation.

Full Text

We can’t show the full text here under this license.

Funding

Competing interests

Competing interests: P.F. is an academic founder of Trace Neuroscience, consults and is a Scientific Advisory Board member for VectorY. B.J.W. is a Scientific Advisory Board member of Quralis. K.E. is a cofounder of Q-State Biosciences, Quralis and Enclear Therapies and is currently employed at BioMarin Pharmaceuticals. J.K.W. and E.K. are academic cofounders of NuCyRNA Therapeutics; E.K. is also an academic cofounder of NeuronGrow and a Scientific Advisory Board member of Axion Biosystems, ResQ Biotech and Synapticure. Named companies were not involved in this project. The other authors declare no competing interests.
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free